Current approved therapeutic strategies for IPF and LC treatment

PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022

Stefania CERRI, Assistant Professor, MD, PhD

A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials, BMC Pulmonary Medicine

A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials, BMC Pulmonary Medicine

Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. - Abstract - Europe PMC

Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials

PDF) Molecular Mechanisms and Cellular Contribution from Lung

Cells, Free Full-Text

JCM, Free Full-Text

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis - ScienceDirect

Alessandro MARCHIONI Università degli Studi di Modena e Reggio

PDF) Molecular Mechanisms and Cellular Contribution from Lung

Stefania CERRI, Assistant Professor, MD, PhD

Georgina COLÓ, PhD, PhD, Biología del Cáncer

34335 PDFs Review articles in CIGARETTE SMOKING